Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis
Our study using an ITS design found that COVID-19 infection was not associated with immediate changes in symptom severity or disability, nor did it change the trajectories of these outcomes over a median follow-up of 18 months. Although results may not generalize to younger people with MS, these findings enhance our general understanding of the consequences of infection in people with MS.
Authors
- Amber Salter (ORCID: https://orcid.org/0000-0002-1088-110X)
- Robert J. Fox (ORCID: https://orcid.org/0000-0002-4263-3717)
- Gary Cutter (ORCID: https://orcid.org/0000-0002-8455-980X)
- Samantha Lancia (ORCID: https://orcid.org/0000-0001-8871-7134)
- Ruth Ann Marrie (ORCID: https://orcid.org/0000-0002-1855-5595)
Institutions
- Cleveland Clinic (US)
- University of Alabama at Birmingham (US)
- University of Manitoba (CA)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1212/wnl.0000000000210149
- Citations
- 7
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.97